Product Information
AUSTEDO XR 6 MG TABLET is a brand product labeled by Teva Neuroscience, Inc., priced at $83.6009 per EA under NDC 68546047056. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Feb 17, 2023.
Strength
6 mg/1
Manufacturer
Teva Neuroscience, Inc.NDC
68546047056
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DEUTETRABENAZINEApproval Type
New Drug (NDA)
FDA Application
NDA216354FDA Approved
2/17/2023
On Market Since
2/21/2023
Price Statistics
The NADAC for AUSTEDO XR 6 MG TABLET has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 7.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $83.6009 per EA |
|---|---|
| All-time high | $84.0210 (Jun 10, 2026) |
| All-time low | $77.2957 (Dec 18, 2024) |
| 52-week high | $84.0210 |
| 52-week low | $79.5930 |
| Median price | $79.5930 |
| Average price | $80.0584 |
| Largest weekly change | +5.5% (Jan 7, 2026) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the deutetrabenazine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AUSTEDO XR 6 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AUSTEDO XR 6 MG TABLET, manufactured by Teva Neuroscience, Inc., is $83.6009 per EA (NDC 68546047056), effective Aug 19, 2026.
How has the price of AUSTEDO XR 6 MG TABLET changed over time?
Over the history we have for it, the NADAC for AUSTEDO XR 6 MG TABLET has risen 7.6%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for AUSTEDO XR 6 MG TABLET?
Since Apr 17, 2024, the NADAC for AUSTEDO XR 6 MG TABLET has ranged from a low of $77.2957 (Dec 18, 2024) to a high of $84.0210 (Jun 10, 2026), with a median of $79.5930 per EA.
Are there cheaper alternatives to AUSTEDO XR 6 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of AUSTEDO XR 6 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AUSTEDO XR 6 MG TABLET?
AUSTEDO XR 6 MG TABLET (NDC 68546047056) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.